These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17542020)

  • 1. Stabilization of proteins by recombinant human gelatins.
    Thyagarajapuram N; Olsen D; Middaugh CR
    J Pharm Sci; 2007 Dec; 96(12):3304-15. PubMed ID: 17542020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure, stability, and complex behavior of recombinant human gelatins.
    Thyagarajapuram N; Olsen D; Middaugh CR
    J Pharm Sci; 2007 Dec; 96(12):3363-78. PubMed ID: 17518362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of bovine granulocyte colony stimulating factor: effect of temperature and pH.
    Kueltzo LA; Middaugh CR
    J Pharm Sci; 2003 Sep; 92(9):1793-804. PubMed ID: 12949998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study.
    Kueltzo LA; Ersoy B; Ralston JP; Middaugh CR
    J Pharm Sci; 2003 Sep; 92(9):1805-20. PubMed ID: 12949999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.
    Iyer V; Hu L; Liyanage MR; Esfandiary R; Reinisch C; Meinke A; Maisonneuve J; Volkin DB; Joshi SB; Middaugh CR
    J Pharm Sci; 2012 Sep; 101(9):3078-90. PubMed ID: 22538529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine.
    Peek LJ; Brey RN; Middaugh CR
    J Pharm Sci; 2007 Jan; 96(1):44-60. PubMed ID: 16998874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective domain stabilization as a strategy to reduce human serum albumin-human granulocyte colony stimulating factor aggregation rate.
    Cordes AA; Carpenter JF; Randolph TW
    J Pharm Sci; 2012 Jun; 101(6):2009-16. PubMed ID: 22422106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative signature diagrams to evaluate biophysical data for differences in protein structure across various formulations.
    Iyer V; Maddux N; Hu L; Cheng W; Youssef AK; Winter G; Joshi SB; Volkin DB; Middaugh CR
    J Pharm Sci; 2013 Jan; 102(1):43-51. PubMed ID: 23160989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of granulocyte colony-stimulating factor and structurally analogous growth factors by anionic phospholipids.
    Rourke AM; Cha Y; Collins D
    Biochemistry; 1996 Sep; 35(36):11913-7. PubMed ID: 8794774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High throughput prediction of the long-term stability of pharmaceutical macromolecules from short-term multi-instrument spectroscopic data.
    Maddux NR; Iyer V; Cheng W; Youssef AM; Joshi SB; Volkin DB; Ralston JP; Winter G; Middaugh CR
    J Pharm Sci; 2014 Mar; 103(3):828-39. PubMed ID: 24421157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor.
    Thirumangalathu R; Krishnan S; Brems DN; Randolph TW; Carpenter JF
    J Pharm Sci; 2006 Jul; 95(7):1480-97. PubMed ID: 16729274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the mode of action of urea on mammalian serum albumins and protective effect of sodium dodecyl sulfate.
    Khan JM; Chaturvedi SK; Khan RH
    Biochem Biophys Res Commun; 2013 Nov; 441(3):681-8. PubMed ID: 24394939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of bovine serum albumin on the secondary structure of interferon alpha 2b as determined by far UV circular dichroism spectropolarimetry.
    Johnston MJ; Nemr K; Hefford MA
    Biologicals; 2010 Mar; 38(2):314-20. PubMed ID: 20031446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New expression method and characterization of recombinant human granulocyte colony stimulating factor in a stable protein formulation.
    Boubeva R; Reichert C; Handrick R; Müller C; Hannemann J; Borcharda G
    Chimia (Aarau); 2012; 66(5):281-5. PubMed ID: 22867536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pH and polyanions on the thermal stability of fibroblast growth factor 20.
    Fan H; Vitharana SN; Chen T; O'Keefe D; Middaugh CR
    Mol Pharm; 2007; 4(2):232-40. PubMed ID: 17397238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective domain stabilization as a strategy to reduce fusion protein aggregation.
    Cordes AA; Platt CW; Carpenter JF; Randolph TW
    J Pharm Sci; 2012 Apr; 101(4):1400-9. PubMed ID: 22234888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protein thermo aggregation on the binding of BSA to gelatin type A.
    Antonov YA; Zhuravleva IL
    Int J Biol Macromol; 2013 Feb; 53():160-7. PubMed ID: 23178344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSA.
    Shi S; Liu J; Joshi SB; Krasnoperov V; Gill P; Middaugh CR; Volkin DB
    J Pharm Sci; 2012 Jun; 101(6):1969-84. PubMed ID: 22411527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of arginine on protein aggregation studied by fluorescence correlation spectroscopy and other biophysical methods.
    Ghosh R; Sharma S; Chattopadhyay K
    Biochemistry; 2009 Feb; 48(5):1135-43. PubMed ID: 19146403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.